Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Personalised Medicine

NCRI Cancer Conference 2016: Day 3 – prostate cancer, iKnife surgery, evolving tumours and more

Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech.

Ada Lovelace Day 2016: from Ada’s coding to computers that analyse cancer

On Ada Lovelace Day 2016, we speak to Dr Bissan Al-Lazikani about how she is using computers to help personalise cancer treatment.

MAP conference 2016: proving the potential of personalised medicine

Last month’s 2016 MAP conference showcased progress so far on personalised cancer treatment, and discussed future challenges.

Harder, better, faster, kinder – a new era for cancer drug testing

Our scientists have developed a new, more accurate way to test hundreds of cancer drugs at the same time.

Study opens door to targeted treatments for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.

From one-eyed lambs to ‘targeted’ skin cancer drugs

Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.

Making a special case – how to boost brain tumour research

Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them.

Balls of cells with their own ‘passport’ to help speed up cancer drug testing

We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.

How imaging could help personalise breast cancer treatment

Advanced imaging technology is helping our scientists understand how key molecules fuel the growth of breast cancer cells.

Inherited gene faults could play greater role in advanced prostate cancer than previously thought

Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease.

Pages